Posts by tag: antibiotic

New Antibiotic Gepotidacin Achieves Breakthrough Against Drug-Resistant Gonorrhea in Major Trial
New Antibiotic Gepotidacin Achieves Breakthrough Against Drug-Resistant Gonorrhea in Major Trial

Kieran Lockhart, May, 22 2025

Gepotidacin, a first-in-class oral antibiotic, has shown a 93% success rate against drug-resistant gonorrhea in a large phase 3 trial, rivalling existing treatments. Oral dosing could boost accessibility, while parallel discoveries target resistant strains. The WHO urges urgent action as resistant gonorrhea becomes harder to treat.

Categories:

Health

Tags:

gepotidacin drug-resistant gonorrhea antibiotic clinical trial

Recent post

  • Kendrick Lamar's Historic Super Bowl Halftime Show Marks a New Era for Hip-Hop
  • Kendrick Lamar's Historic Super Bowl Halftime Show Marks a New Era for Hip-Hop
  • Can the Jacksonville Jaguars win Super Bowl 57?
  • Can the Jacksonville Jaguars win Super Bowl 57?
  • Manchester City Triumphs Over Leyton Orient in Thrilling FA Cup Fourth Round Comeback
  • Manchester City Triumphs Over Leyton Orient in Thrilling FA Cup Fourth Round Comeback
  • Salman Rushdie's Attacker Hadi Matar Gets 25-Year Prison Sentence in New York Stabbing Case
  • Salman Rushdie's Attacker Hadi Matar Gets 25-Year Prison Sentence in New York Stabbing Case
  • Joseph Parker Dominates Martin Bakole with Stunning Riyadh Knockout
  • Joseph Parker Dominates Martin Bakole with Stunning Riyadh Knockout

Categories

  • Sports
  • Entertainment
  • World News
  • Politics
  • Business
  • Technology
  • Football
  • Crime
  • Music
  • Sports News

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • August 2023
  • July 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023

Tags

Premier League football Manchester United Barcelona IPL 2025 Trump Arsenal transfer Chelsea Real Madrid Championship La Liga Rangers winning numbers National Lottery Pacers Knicks super bowl Leicester City Pakistan

© 2025. All rights reserved.